Navigation Links
VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD
Date:7/1/2009

Hollywood, FL July 1, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found VYVANSE (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults with Attention Deficit Hyperactivity Disorder (ADHD). VYVANSE is the first approved stimulant for adults with ADHD to be evaluated in this setting, and these data were presented today at the 49th annual New Clinical Drug Evaluation Unit meeting in Hollywood, FL. VYVANSE is currently approved by the US Food and Drug Administration (FDA) for the treatment of ADHD in children age 6 to 12 years and in adults with ADHD.

"Long-acting medication may be important for adults with ADHD because ADHD symptoms, such as inattention, hyperactivity, and impulsivity, may impact them at work, as well as in at least one other area of their life," said Matthew Brams, MD, study author and psychiatrist in private practice with Bayou City Research, Ltd in Houston. "In this study, adults taking VYVANSE demonstrated significant efficacy as measured by the Permanent Product Measure of Performance (PERMP), from two hours, the first time point measured, up to 14 hours following administration. Additionally, adults taking VYVANSE demonstrated significant ADHD symptom improvement, as measured by the ADHD Rating Scale (ADHD-RS) with adult prompts. These findings may be important for adults who require ADHD symptom management at work, at home, and in social settings."

In this study, investigators evaluated adults with ADHD in an adult simulated workplace environment setting. In this setting, adults engaged in tests and activities that require a level of attention needed in many workplace settings. The efficacy of VYVANSE was measured by PERMP, a validated, time sensitive, skill adjusted math test designed to evaluate an adult's ability t
'/>"/>

Contact: Matthew Cabrey (Shire North America)
484-595-8248
Porter Novelli
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
2. VYVANSE provided behavior, inattention and math test score improvements in children with ADHD
3. Phase III pivotal results presented of VYVANSE to treat ADHD in adults
4. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
5. FDA approves additional dosage strengths of Vyvanse
6. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
7. VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment
8. Record Number of Volunteers Provided Free Dental Care to Needy Children in Minnesota
9. Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
10. National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus
11. $5.15 Million Provided to Support Local Health Care Needs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... WOODCLIFFLAKE,N.J.,Nov.25/PRNewswire-FirstCall/--...nouncedtheresultsofits"ModifiedDutchAuction"tender...000,000aggregateprincipalamount,oruptoapproximatel...vertibleNotesdue2010. ,, BasedonthecountbyAmeri...yforthetenderoffer,$30,805,000aggregateprincipalam...
(Date:11/25/2009)...onal South American medicinal herb proves effectiv... (HealthDay News) -- An herb called Brazilian mint...s, English researchers report. , Traditional he...enata to treat a range of health problems, includ...tudy is the first to scientifically prove the pain...
(Date:11/25/2009)... Thirty-seven million Americans ... minimally invasive technology for treating chroni...al Center in Jackson, Miss. The Balloon Sinuplasty...theter and balloon to quickly open and expand bloc...vember 25, 2009 -- A clinically proven, minimally ...
(Date:11/25/2009)... Dentistry is evolving beyond th...akeovers. In fact, it is looking at these more tra... preservation and beauty of teeth is what the publ...re now, more than ever, an important part of the m...en oral and systemic health is being strengthened ...
(Date:11/25/2009)... Adam DreamHealer’s Global...ng intentions changes the physiology of someone at... intentions at a time unknown to a volunteer who w...nalyzed by world experts in the USA and Canada. ,...ember 25, 2009 -- Adam DreamHealer’s Globa...
Breaking Medicine News(10 mins):Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 3Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 3Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2
...dequate health care at reasonable cost is a nation...le in the United States. It is also the issue that...a National Health Program, will address at NJITs T... care, endangers the health of millions. , More ...
...funds for Latino Mental Health Training Program, ...e sixth year in a row since her untimely death, hu..."finish the race" for Dr. Cynthia,Lucero, the tale...ultural immersion to create culturally sensitive a...
... method might leave women less tired, researchers ...of two commonly used radiation treatments for earl... patient,s immune system, concludes a Loyola Unive... my body?, This study helps allay some fears," lea...
...ronger Voice for Patient Care, AUGUSTA, Maine, Oc... in Bangor, Maine appears to be over -- and a stri...istered nurses and hospital officials Thursday nig...e Maine State,Nurses Association/National Nurses O...
...t. 12 , Statement by Chris Cathcart,... for a detailed review of the,epidemiological stud...not,make any definitive comment on this specific s...onstrate a true,cause-and- effect relationship. Ne...
...key October 12, 2007 - Central venous catheters a... for patients with serious kidney disease. One tec..., has been commonly used worldwide in recent years...syndrome (SVC syndrome), a highly serious complica...
Other Medicine News:Health News:Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast 2Health News:Breast Cancer Radiation Won't Hurt Immune Health 2Health News:MSNA: Strike Averted - Tentative Pact at EMMC 2Health News:Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma 2
(Date:11/25/2009)...,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(...gpoint-of-carebloodanalysissystems,announcedtodayt...willpresentatthe21stAnnualPiperJaffrayHealthCareCo...conferencewillbeheldattheNewYorkPalaceHotelinNewYo...anufacturesandmarketsportablebloodanalysissystemsf...
(Date:11/25/2009)...L,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticalsIn...andchiefexecutiveofficer,willpresentatthePiperJaff...ember1,2009,atTheNewYorkPalaceHotelinNewYorkCity.D...eadingantibioticclinicalprogramsforthetreatmentofd...empraPharmaceuticals ,, Foundedin2006,CempraPh...
(Date:11/25/2009)...M,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--Hea...eadinginnovatorandprovideroflessinvasive,miniaturi...etreatmentofadvancedheartfailure,todayannouncedtha...tAnnualPiperJaffrayHealthCareConferenceat8:00amEST...dattheNewYorkPalaceHotel,December1-2. ,, Alivew...
Breaking Medicine Technology:Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 1Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 4Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Aquafresh 28R 29 Celebrates Amazing Moms in Phoenix 5137 1Aquafresh 28R 29 Celebrates Amazing Moms in Phoenix 5137 2
...hera Pharmaceuticals,Inc., a privately-held biopha...of a second Phase IIb clinical trial of A-002, for...second study, administration of once-daily,A-002 l...positive effects,of A-002 treatment seen in the tw...erological Markers of Atherosclerosis) announced i...
... on Testing of Juvaris JVRS-100 as an, Adjuvant wi...s protection, PLEASANTON, Calif., Jan. 15 Juvari...nters for Disease Control and Prevention,and Juvar...rative Research,and Development Agreement (CRADA) ...andemic influenza vaccine. The ability of JVRS-100...
Other Medicine Technology:Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial 2Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention 2Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: